The Sunday Summary provides an overview of Hardman & Co research published over the past seven days, as well as an update on other Hardman happenings.
Hardman & Co Monthly
Company updates + February feature article
Corporate Research | 2 February 2026
Hardman Talks | 2025 in UK healthcare: rebound or warning sign? After a rebound in UK healthcare equities in 2025, the sector still faces major challenges. In this episode of Hardman Talks, Keith Hiscock sits down with Dr Martin Hall, Head of Life Sciences, to discuss why funding is tight, why commercialisation remains difficult and what this means for UK small cap healthcare companies.
